Open AccessSubpopulations at Risk for Not Completing Once Weekly 12-Dose Regimen of Isoniazid Plus Rifapentine for Treatment of Latent Tuberculosis Infection in United States Tuberculosis Programs
Author(s) -
Nwabunie Nwana,
Christine Ho,
Amy L. Sandul,
Sapna Bamrah Morris,
Suzanne M. Marks
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.434
Subject(s) - rifapentine , medicine , isoniazid , latent tuberculosis , regimen , tuberculosis , mycobacterium tuberculosis , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom